Skip to search formSkip to main contentSkip to account menu

Neuroendocrine Cell Hyperplasia of Infancy

Known as: NEHI 
A form of interstitial lung disease characterized by increased numbers of pulmonary neuroendocrine cells, typically presenting in the first year of… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Neuroendocrine cell hyperplasia of infancy (NEHI) is a disease of the unknown etiology which is one of the rare, insufficiently… 
Highly Cited
2013
Highly Cited
2013
BACKGROUND Neuroendocrine cell hyperplasia of infancy (NEHI) is a childhood diffuse lung disease of unknown etiology. We… 
Highly Cited
2013
Highly Cited
2013
Lung function in children with neuroendocrine cell hyperplasia of infancy (NEHI) and correlations with future clinical outcomes… 
2013
2013
OBJECTIVE: Neuroendocrine cell hyperplasia of infancy (NEHI) is a form of childhood interstitial lung disease characterized by… 
2012
2012
Neuroendocrine cell hyperplasia of infancy (NEHI) has recently been described as an obstructive airway disease that affects… 
Highly Cited
2011
Highly Cited
2011
BACKGROUND The diagnostic gold standard for neuroendocrine cell hyperplasia of infancy (NEHI) is demonstration of increased… 
Review
2010
Review
2010
OBJECTIVE Neuroendocrine cell hyperplasia of infancy is a form of childhood interstitial lung disease originally reported as… 
Highly Cited
2010
Highly Cited
2010
Neuroendocrine cell hyperplasia of infancy (NEHI) is a recently described children's interstitial lung disease (chILD) disorder… 
Review
2007
Review
2007
RATIONALE Considerable confusion exists regarding nomenclature, classification, and management of pediatric diffuse lung diseases… 
2006
2006
NEHI is a newly described diffuse lung disease of children. Children with NEHI usually present before the age of 2 years with…